Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
Saved in:
Main Authors: | Fanglei Zuo (Author), Rui Sun (Author), Hassan Abolhassani (Author), Likun Du (Author), Yating Wang (Author), Stelios Vlachiotis (Author), Federico Bertoglio (Author), Maren Schubert (Author), Nima Rezaei (Author), Zahra Chavoshzadeh (Author), Concetta Guerra (Author), Andrea Cavalli (Author), Juni Andréll (Author), Makiko Kumagai-Braesch (Author), Yintong Xue (Author), Yunlong Cao (Author), Michael Hust (Author), Davide F. Robbiani (Author), Xiaoliang Sunney Xie (Author), Lennart Hammarström (Author), Harold Marcotte (Author), Qiang Pan-Hammarström (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
by: Rahatul Islam, et al.
Published: (2023) -
XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillance
by: Joseph Fokam, et al.
Published: (2024) -
Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England
by: Catherine Quinot, et al.
Published: (2024) -
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
by: Silvia Sutandhio, et al.
Published: (2023) -
Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection
by: Jin-Jin Chen, et al.
Published: (2023)